SAM
RVMD icon

Smartleaf Asset Management’s Revolution Medicines RVMD Stock Holding History

Smartleaf Asset Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.9K Sell
150
-63
-30% -$6.36K ﹤0.01% 2156
2025
Q4 		$17K Buy
213
+55
+35% +$3.61K ﹤0.01% 2120
2025
Q3 		$7.28K Buy
158
+35
+28% +$1.37K ﹤0.01% 2236
2025
Q2 		$4.54K Sell
123
-216
-64% -$8.3K ﹤0.01% 2086
2025
Q1 		$12.7K Sell
339
-149
-31% -$6.05K ﹤0.01% 1836
2024
Q4 		$21.1K Buy
488
+110
+29% +$5.55K ﹤0.01% 1611
2024
Q3 		$16.7K Buy
378
+151
+67% +$6.58K ﹤0.01% 1454
2024
Q2 		$8.75K Buy
+227
New +$8.48K ﹤0.01% 1479

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Smartleaf Asset Management's RVMD Position: Q1 2026 in Review

Smartleaf Asset Management reduced its Revolution Medicines (RVMD) stake by 30% in Q1 2026, selling an estimated $6.36K and leaving 150 shares worth $13.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2156.

Smartleaf Asset Management first reported a position in RVMD in Q2 2024 and has held it in 8 quarters since. The position peaked at $21.1K in Q4 2024. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Smartleaf Asset Management held 150 shares of Revolution Medicines worth $13.9K as of Q1 2026.
  • Smartleaf Asset Management sold 63 Revolution Medicines shares in Q1 2026, an estimated $6.36K.
  • Revolution Medicines made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #2156 holding.
  • Smartleaf Asset Management first reported a position in Revolution Medicines in Q2 2024 and has held it in 8 quarters since.
  • Smartleaf Asset Management's Revolution Medicines position peaked at $21.1K in Q4 2024.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.